Manuscripts and Publications

Filters: Keyword is Male  [Clear All Filters]
2009
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM et al..  2009.  Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.. Hum Genet. 126(5):685-96.
Chutuape KS, Ziff M, Auerswald C, Castillo M, McFadden A, Ellen J.  2009.  Examining differences in types and location of recruitment venues for young males and females from urban neighborhoods: findings from a multi-site HIV prevention study.. J Urban Health. 86(1):31-42.
Naar-King S, Parsons JT, Murphy DA, Chen X, D Harris R, Belzer ME.  2009.  Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors.. Arch Pediatr Adolesc Med. 163(12):1092-8.
Rudy BJ, Murphy DA, D Harris R, Muenz L, Ellen J.  2009.  Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions.. AIDS Patient Care STDS. 23(3):185-94.
Jamil OB, Harper GW, M Fernández I.  2009.  Sexual and ethnic identity development among gay-bisexual-questioning (GBQ) male ethnic minority adolescents.. Cultur Divers Ethnic Minor Psychol. 15(3):203-14.
Wilson EC, Garofalo R, Harris RD, Herrick A, Martinez M, Martinez J, Belzer M.  2009.  Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work.. AIDS Behav. 13(5):902-13.
Jennings JM, Ellen JM, Deeds BGriffin, D Harris R, Muenz LR, Barnes W, Lee SS, Auerswald CL.  2009.  Youth living with HIV and partner-specific risk for the secondary transmission of HIV.. Sex Transm Dis. 36(7):439-44.
2010
Sill AM, Constantine NT, Wilson CM, Peralta L.  2010.  Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.. J Adolesc Health. 46(1):93-6.
Murphy DA, Lam P, Naar-King S, D Harris R, Parsons JT, Muenz LR.  2010.  Health literacy and antiretroviral adherence among HIV-infected adolescents.. Patient Educ Couns. 79(1):25-9.
Barnes W, D'Angelo L, Yamazaki M, Belzer M, Schroeder S, Palmer-Castor J, Futterman D, Kapogiannis B, Muenz L, D Harris R et al..  2010.  Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing.. Arch Pediatr Adolesc Med. 164(3):273-6.
Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K.  2010.  Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination.. Vaccine. 28(21):3672-8.
Chutuape KS, Willard N, Sanchez K, Straub DM, Ochoa TN, Howell K, Rivera C, Ramos I, Ellen JM.  2010.  Mobilizing communities around HIV prevention for youth: how three coalitions applied key strategies to bring about structural changes.. AIDS Educ Prev. 22(1):15-27.
Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H.  2010.  Multiple risk behaviors among youth living with human immunodeficiency virus in five U.S. cities.. J Adolesc Health. 46(1):11-6.
Naar-King S, Parsons JT, Murphy D, Kolmodin K, D Harris R.  2010.  A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression.. J Adolesc Health. 46(5):422-8.
Wilson BDM, Harper GW, Hidalgo MA, Jamil OB, Torres RSebastián, M Fernández I.  2010.  Negotiating dominant masculinity ideology: strategies used by gay, bisexual and questioning male adolescents.. Am J Community Psychol. 45(1-2):169-85.
Outlaw AY, Naar-King S, Janisse H, Parsons JT.  2010.  Predictors of condom use in a multisite study of high-risk youth living with HIV.. AIDS Educ Prev. 22(1):1-14.
Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW.  2010.  Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.
Rudy BJ, Murphy DA, D Harris R, Muenz L, Ellen J.  2010.  Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States.. AIDS Patient Care STDS. 24(2):97-104.
Naar-King S, Kolmodin K, Parsons JT, Murphy D.  2010.  Psychosocial factors and substance use in high-risk youth living with HIV: a multi-site study.. AIDS Care. 22(4):475-82.
Cunningham CK, Rudy BJ, Xu J, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn PM.  2010.  Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.. Pediatr Infect Dis J. 29(6):530-4.
Wilson EC, Garofalo R, D Harris R, Belzer M.  2010.  Sexual risk taking among transgender male-to-female youths with different partner types.. Am J Public Health. 100(8):1500-5.
Nugent NR, Brown LK, Belzer M, Harper GW, Nachman S, Naar-King S.  2010.  Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk.. J Int Assoc Physicians AIDS Care (Chic). 9(2):113-5.
2012
Bruce D, Harper GW, M Fernández I, Jamil OB.  2012.  Age-concordant and age-discordant sexual behavior among gay and bisexual male adolescents.. Arch Sex Behav. 41(2):441-8.
Murphy DA, Chen X, Naar-King S, Parsons JT.  2012.  Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth.. AIDS Patient Care STDS. 26(2):95-100.
Willard N, Chutuape K, Stines S, Ellen JM.  2012.  Bridging the gap between individual-level risk for HIV and structural determinants: using root cause analysis in strategic planning.. J Prev Interv Community. 40(2):103-17.
Lin AJ, Dudek JC, Francisco VT, Castillo M, Freeman P, Martinez M, Sniecinski K, Young K, Ellen JM.  2012.  Challenges and approaches to mobilizing communities for HIV prevention among young men who have sex with men of color.. J Prev Interv Community. 40(2):149-64.
Miller RLin, Reed SJ, Francisco VT, Ellen JM.  2012.  Conflict transformation, stigma, and HIV-preventive structural change.. Am J Community Psychol. 49(3-4):378-92.
Castillo M, Palmer BJ, Rudy BJ, Fernandez MIsabel.  2012.  Creating partnerships for HIV prevention among YMSM: the Connect Protect® Project and House and Ball Community in Philadelphia.. J Prev Interv Community. 40(2):165-75.
Tanney MR, Naar-King S, MacDonnel K.  2012.  Depression and stigma in high-risk youth living with HIV: a multi-site study.. J Pediatr Health Care. 26(4):300-5.
Robles-Schrader GM, Harper GW, Purnell M, Monarrez V, Ellen JM.  2012.  Differential challenges in coalition building among HIV prevention coalitions targeting specific youth populations.. J Prev Interv Community. 40(2):131-48.
Mulligan K, D Harris R, Emmanuel P, Fielding RA, Worrell C, Kapogiannis BG, Monte D, Sleasman J, Wilson CM, Aldrovandi GM.  2012.  Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.. Clin Infect Dis. 55(3):461-8.
Dempsey AG, Macdonell KE, Naar-King S, Lau C-Y.  2012.  Patterns of disclosure among youth who are HIV-positive: a multisite study.. J Adolesc Health. 50(3):315-7.
Aaron KJ, Kempf M-C, Christenson RH, Wilson CM, Muntner P, Shrestha S.  2012.  Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.. J Acquir Immune Defic Syndr. 61(4):499-506.
Reed SJ, Miller RLin, Francisco VT.  2012.  Programmatic capacity and HIV structural change interventions: influences on coalitions' success and efficiency in accomplishing intermediate outcomes.. J Prev Interv Community. 40(2):118-30.
Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB.  2012.  Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.. J Clin Endocrinol Metab. 97(11):4004-13.
Martinez J, Lemos D, Hosek S.  2012.  Stressors and sources of support: the perceptions and experiences of newly diagnosed Latino youth living with HIV.. AIDS Patient Care STDS. 26(5):281-90.
Agwu AL, Bethel J, Hightow-Weidman LB, Sleasman JW, Wilson CM, Rudy B, Kapogiannis BG.  2012.  Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.. AIDS Patient Care STDS. 26(4):193-6.
Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD et al..  2012.  Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.. Clin Infect Dis. 54(7):1013-25.
2013
Hosek SG, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, M Fernández I, Rutledge B, Martinez J, Garofalo R et al..  2013.  The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men.. J Acquir Immune Defic Syndr. 62(4):447-56.
Bruce D, Kahana S, Harper GW, M Fernández I.  2013.  Alcohol use predicts sexual risk behavior with HIV-negative or partners of unknown status among young HIV-positive men who have sex with men.. AIDS Care. 25(5):559-65.
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.  2013.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.. AIDS Res Hum Retroviruses. 29(3):493-500.
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SEllen, Hoffman D, Wilson CM et al..  2013.  Comprehension of a simplified assent form in a vaccine trial for adolescents.. J Med Ethics. 39(6):410-2.
Reed SJ, Miller RLin.  2013.  Connect to protect and the creation of AIDS-competent communities.. AIDS Educ Prev. 25(3):255-67.
Mullins TLK, Rudy BJ, Wilson CM, Sucharew H, Kahn JA.  2013.  Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.. Int J STD AIDS. 24(2):123-7.
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ.  2013.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.. J Pediatr Psychol. 38(6):638-48.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD.  2013.  Preventive misconception and adolescents' knowledge about HIV vaccine trials.. J Med Ethics. 39(12):765-71.
Harper GW, Fernandez IM, Bruce D, Hosek SG, Jacobs RJ.  2013.  The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV.. AIDS Behav. 17(1):213-23.
Bruce D, Harper GW, Suleta K.  2013.  Sexual risk behavior and risk reduction beliefs among HIV-positive young men who have sex with men.. AIDS Behav. 17(4):1515-23.
2014
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Whiteley LB, Brown LK, Swenson R, Kapogiannis BG, Harper GW.  2014.  Disparities in mental health care among HIV-infected youth.. J Int Assoc Provid AIDS Care. 13(1):29-34.
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.  2014.  Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
Brothers J, Harper GW, M Fernández I, Hosek SG.  2014.  EVOLUTION--taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV.. AIDS Patient Care STDS. 28(1):33-42.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2014.  Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.. AIDS Behav. 18(8):1501-10.
Ellen JM, Kapogiannis B, J Fortenberry D, Xu J, Willard N, Duval A, Pace J, Loeb J, Monte D, Bethel J.  2014.  HIV viral load levels and CD4+ cell counts of youth in 14 cities.. AIDS. 28(8):1213-9.
Outlaw AY, Naar-King S, Tanney M, Belzer ME, Aagenes A, Parsons JT, Merlo LJ.  2014.  The initial feasibility of a computer-based motivational intervention for adherence for youth newly recommended to start antiretroviral treatment.. AIDS Care. 26(1):130-5.
Philbin MM, Tanner AE, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care.. AIDS Care. 26(1):12-9.
Harper GW, Bruce D, Hosek SG, M Fernández I, Rood BA.  2014.  Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention.. AIDS Patient Care STDS. 28(12):666-76.
Harper GW, Lemos D, Hosek SG.  2014.  Stigma reduction in adolescents and young adults newly diagnosed with HIV: findings from the Project ACCEPT intervention.. AIDS Patient Care STDS. 28(10):543-54.
Esposito-Smythers C, Brown LK, Wolff J, Xu J, Thornton S, Tidey J.  2014.  Substance abuse treatment for HIV infected young people: an open pilot trial.. J Subst Abuse Treat. 46(2):244-50.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur AH, Clark LF.  2014.  The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2014.  Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.. Antivir Ther. 19(6):613-8.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  "Youth friendly" clinics: considerations for linking and engaging HIV-infected adolescents into care.. AIDS Care. 26(2):199-205.
2015
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD.  2015.  Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
Gilbert ALewis, Knopf AS, J Fortenberry D, Hosek SG, Kapogiannis BG, Zimet GD.  2015.  Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.  2015.  Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
Mullins TLKowalczy, Lally M, Zimet G, Kahn JA.  2015.  Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.. AIDS Patient Care STDS. 29(4):193-203.
Havens PL, Hazra R.  2015.  Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.. Pediatr Infect Dis J. 34(4):406-8.
Saberi P, Mayer K, Vittinghoff E, Naar-King S.  2015.  Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.. AIDS Behav. 19(1):93-103.
Ellen JM, Greenberg L, Willard N, Stines S, Korelitz J, Boyer CB.  2015.  Cross-sectional survey comparing HIV risk behaviours of adolescent and young adult men who have sex with men only and men who have sex with men and women in the U.S. and Puerto Rico.. Sex Transm Infect. 91(6):458-61.
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB et al..  2015.  Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
Cook SH, Valera P, Wilson PA.  2015.  HIV status disclosure, depressive symptoms, and sexual risk behavior among HIV-positive young men who have sex with men.. J Behav Med. 38(3):507-17.
Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G et al..  2015.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.. J Acquir Immune Defic Syndr. 69(1):52-60.
Bruce D, Kahana SY, Bauermeister JA, Nichols SL, Hightow-Weidman LB, Heinze JE, Shea J, M Fernández I.  2015.  Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS.. Drug Alcohol Depend. 151:173-80.
M Fernández I, Huszti HC, Wilson PA, Kahana S, Nichols S, Gonin R, Xu J, Kapogiannis BG.  2015.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.. AIDS Behav. 19(5):918-30.
Brown LK, Whiteley L, Harper GW, Nichols S, Nieves A.  2015.  Psychological symptoms among 2032 youth living with HIV: a multisite study.. AIDS Patient Care STDS. 29(4):212-9.
Hussen SA, Harper GW, Bauermeister JA, Hightow-Weidman LB.  2015.  Psychosocial influences on engagement in care among HIV-positive young black gay/bisexual and other men who have sex with men.. AIDS Patient Care STDS. 29(2):77-85.
Kahana SY, Fernandez MIsabel, Wilson PA, Bauermeister JA, Lee S, Wilson CM, Hightow-Weidman LB.  2015.  Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.. J Acquir Immune Defic Syndr. 68(2):169-77.

Pages